MRK vs UNH
By Alex · Tickerpine
Merck & Co., Inc. vs UnitedHealth Group Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | UNH |
|---|---|---|
| Price | $144.30 | $371.90 |
| Market cap | $356.01B | $333.82B |
| P/E ratio | 114.5 | 23.9 |
| ROE | 6.96% | 14.15% |
| Profit margin | 4.77% | 3.14% |
| Revenue growth | 5.10% | 0.40% |
| Dividend yield | 2.36% | 2.50% |
| Beta | 0.23 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs UNH in plain English
- MRK and UNH are similar in size.
- UNH is cheaper on earnings (P/E 23.9 vs 114.5).
- UNH earns a higher return on equity (14% vs 7%).
- MRK is growing revenue faster (5% vs 0%).
- UNH has the higher dividend yield (2.50% vs 2.36%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.